Literature DB >> 3501244

Acute inflammation and a Shwartzman-like reaction induced by interleukin-1 and tumor necrosis factor. Synergistic action of the cytokines in the induction of inflammation and microvascular injury.

H Z Movat1, C E Burrowes, M I Cybulsky, C A Dinarello.   

Abstract

A Shwartzman-like reaction was elicited in rabbits by preparing the skin with intradermal injections of recombinant human tumor necrosis factor alpha (TNF alpha) and recombinant human interleukin-1 (IL-1 alpha or beta). The animals were challenged intravenously with endotoxin or by intravascular activation of complement with immune complexes or zymosan 18 hours later and were sacrificed after another 2 hours. Animals challenged with saline did not develop Shwartzman-like reactions. The sites prepared with endotoxin or with either form of IL-1 plus TNF alpha developed visible hemorrhage, whereas sites injected with either IL-1 or TNF alpha alone did not. Hemorrhage and microthrombosis were quantitated with 59Fe-labeled erythrocytes and 111In-platelets for 2 hours after the intravenous challenge, and the findings confirmed the observations made on gross inspection. Dermal sites prepared with the cytokines and challenged intravenously with endotoxin, immune complexes, or zymosan exhibited some diffuse hemorrhage and an intense erythrocyte extravasation around distended vessels, along skin appendages, and the panniculus carnosus muscle. The lumens of many large and postcapillary venules contained aggregates of platelets and leukocytes. These changes were superimposed on those seen at prepared sites (leukocyte infiltration). By electron microscopy fibrin was demonstrable in association with the formed elements of the blood. Histologic examination of the 18-hour-old preparative lesions or 20-hour-old lesions of saline-"challenged" animals revealed accumulation of leukocytes in the dermis, predominantly neutrophils. This accumulation was sparse at sites treated with only IL-1 or TNF alpha, but very intense at sites treated with both IL-1 and TNF alpha or with endotoxin. These observations were confirmed quantitatively by measuring the accumulation of 51Cr-labeled neutrophils for 2 hours after injection. The potency of IL-1 alpha was comparable to that in our earlier report, and TNF alpha was about three log times less potent. Sites treated with both IL-1 alpha and TNF alpha resulted in 69% greater neutrophil emigration than the additive response elicited by each cytokine. The reported findings implicate a synergism between IL-1 and TNF alpha in the induction of both the inflammatory reaction (preceding the Shwartzman reaction) and the thrombohemorrhagic component of the Shwartzman reaction proper.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3501244      PMCID: PMC1899823     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  20 in total

1.  The role of PMN-leucocyte lysosomes in tissue injury, inflammation and hypersensitivity. VI. The participation of the PMN-leucocyte and the blood platelet in systemic aggregate anaphylaxis.

Authors:  H Z Movat; T Uriuhara; N S Taichman; H C Rowsell; J F Mustard
Journal:  Immunology       Date:  1968-05       Impact factor: 7.397

2.  Passive immunization against cachectin/tumor necrosis factor protects mice from lethal effect of endotoxin.

Authors:  B Beutler; I W Milsark; A C Cerami
Journal:  Science       Date:  1985-08-30       Impact factor: 47.728

3.  The role of interleukin-1 in neutrophil leukocyte emigration induced by endotoxin.

Authors:  M I Cybulsky; I G Colditz; H Z Movat
Journal:  Am J Pathol       Date:  1986-09       Impact factor: 4.307

4.  Neutropenic responses to intradermal injections of Escherichia coli. Effects on the kinetics of polymorphonuclear leukocyte emigration.

Authors:  M I Cybulsky; I J Cybulsky; H Z Movat
Journal:  Am J Pathol       Date:  1986-07       Impact factor: 4.307

5.  The in vivo quantitation and kinetics of monocyte migration into acute inflammatory tissue.

Authors:  T B Issekutz; A C Issekutz; H Z Movat
Journal:  Am J Pathol       Date:  1981-04       Impact factor: 4.307

6.  Interleukin 1 and lipopolysaccharide induce an inhibitor of tissue-type plasminogen activator in vivo and in cultured endothelial cells.

Authors:  J J Emeis; T Kooistra
Journal:  J Exp Med       Date:  1986-05-01       Impact factor: 14.307

7.  Studies on the mechanism of the Shwartzman phenomenon; similarities between reactions to endotoxins and certain reactions of bacterial allergy.

Authors:  C A STETSON
Journal:  J Exp Med       Date:  1955-04-01       Impact factor: 14.307

8.  Tumor necrosis factor (cachectin) is an endogenous pyrogen and induces production of interleukin 1.

Authors:  C A Dinarello; J G Cannon; S M Wolff; H A Bernheim; B Beutler; A Cerami; I S Figari; M A Palladino; J V O'Connor
Journal:  J Exp Med       Date:  1986-06-01       Impact factor: 14.307

9.  Interleukin 1 (IL-1) induces biosynthesis and cell surface expression of procoagulant activity in human vascular endothelial cells.

Authors:  M P Bevilacqua; J S Pober; G R Majeau; R S Cotran; M A Gimbrone
Journal:  J Exp Med       Date:  1984-08-01       Impact factor: 14.307

10.  Modulation of endothelial cell hemostatic properties by tumor necrosis factor.

Authors:  P P Nawroth; D M Stern
Journal:  J Exp Med       Date:  1986-03-01       Impact factor: 14.307

View more
  60 in total

1.  Mechanisms of edema formation in experimental autoimmune encephalomyelitis. The contribution of inflammatory cells.

Authors:  L Claudio; Y Kress; J Factor; C F Brosnan
Journal:  Am J Pathol       Date:  1990-11       Impact factor: 4.307

2.  Pathophysiologic effect of interleukin-1b in the rabbit retina.

Authors:  J A Martiney; M Litwak; J W Berman; J C Arezzo; C F Brosnan
Journal:  Am J Pathol       Date:  1990-12       Impact factor: 4.307

Review 3.  Is granulocyte or endothelial cell activation responsible for the initiation of granulocyte recruitment during acute inflammation?

Authors:  C J Whelan
Journal:  Agents Actions       Date:  1992-11

4.  Effect of hepatocyte apoptosis induced by TNF-alpha on acute severe hepatitis in mouse models.

Authors:  Guo-Qing Zang; Xia-Qiu Zhou; Hong Yu; Qing Xie; Guo-Ming Zhao; Bin Wang; Qing Guo; Yue-Qin Xiang; Dan Liao
Journal:  World J Gastroenterol       Date:  2000-10       Impact factor: 5.742

5.  Effects of recombinant monokines on hepatic pyruvate dehydrogenase, pyruvate dehydrogenase kinase, lipogenesis de novo and plasma triacylglycerols. Abolition by prior fasting.

Authors:  M Blackham; D Cesar; O J Park; T C Vary; K Wu; S Kaempfer; C H Shackleton; M K Hellerstein
Journal:  Biochem J       Date:  1992-05-15       Impact factor: 3.857

6.  Persistence of local cytokine production in shigellosis in acute and convalescent stages.

Authors:  R Raqib; A A Lindberg; B Wretlind; P K Bardhan; U Andersson; J Andersson
Journal:  Infect Immun       Date:  1995-01       Impact factor: 3.441

7.  Endotoxin, interleukin-1, and tumor necrosis factor cause neutrophil-dependent microvascular leakage in postcapillary venules.

Authors:  E S Yi; T R Ulich
Journal:  Am J Pathol       Date:  1992-03       Impact factor: 4.307

8.  An effector role for platelets in systemic and local lipopolysaccharide-induced toxicity in mice, mediated by a CD11a- and CD54-dependent interaction with endothelium.

Authors:  P F Piguet; C Vesin; J E Ryser; G Senaldi; G E Grau; F Tacchini-Cottier
Journal:  Infect Immun       Date:  1993-10       Impact factor: 3.441

9.  Human polymorphonuclear leucocytes stimulated by tumour necrosis factor-alpha show increased adherence to extracellular matrix proteins which is mediated via the CD11b/18 complex.

Authors:  H L Thompson; K Matsushima
Journal:  Clin Exp Immunol       Date:  1992-11       Impact factor: 4.330

10.  Effect of soluble P55 tumour-necrosis factor binding fusion protein on the local Shwartzman and Arthus reactions.

Authors:  K E Norman; T J Williams; M Feldmann; A G Rossi
Journal:  Br J Pharmacol       Date:  1996-02       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.